It has been shown to activate nuclear factor erythroid 2-related factor 2 (Nrf2) [47,48], enhancing cellular antioxidant responses and reducing hepatic oxidative stress, a major contributor to MASLD progression. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.